Pharmaceutical & Diagnostic Innovation

, Volume 3, Issue 6, pp 19–22 | Cite as

Corporate Activity — Mergers and Acquisitions

News & View

In this section we bring you a summary of corporate transactions in the pharmaceutical and diagnostic industries. For your convenience, the transactions are listed in alphabetical order within each category. If you are seeking information about a specific company, the quickest method of locating it is to search this issue’s company index (p33).

Impending mergers and acquisitions

Actavis Group, an international generic pharmaceuticals company headquartered in Iceland, is to acquire Amide Pharmaceutical, a privately owned US generic pharmaceuticals company. The deal will see Actavis acquire Amide for an initial gross consideration of $US500 million in cash with up to an additional $US100 million payable over two years subject to performance. The deal brings together two premier generics companies with complementary strengths in Europe and the US and represents a significant milestone in Actavis’ plans to become one of the leading global companies within the sector. The combined company...

Copyright information

© Adis Data Information BV 2005

Personalised recommendations